Dr Kasper on the FDA Approval of Nirogacestat in Desmoid Tum

Bernd Kasper, MD, PhD, discusses the significance of the FDA approval of nirogacestat for patients with desmoid tumors.

Related Keywords

Bernd Kasper , Mannheim University Medical Center , Interdisciplinary Tumor Center Mannheim , University Of Heidelberg , Sarcoma Unit , D , Phd , Fda Approval Of Nirogacestat , Patients With Desmoid Tumors ,